Acetyl Hexapeptide 3 (Argireline) 200mg
Misc (Generics)
Cosmetic active ingredient – anti-ageing peptideTopical neuropeptide (Argireline) for anti-wrinkle skincare formulations
Certifications
- Marketed and positioned as a cosmetic/technical peptide ingredient (Argireline) for use in anti Ageing skincare formulations; it is not presented as a licensed medicinal product or medical device.
- No specific GMP certificates, ISO certifications, cosmetic notification references (e.g. CPNP) or other regulatory approvals for this particular 200 mg product are publicly listed by the seller.
- Argireline (Acetyl Hexapeptide 8/3) is widely used as a cosmetic ingredient globally and is discussed in cosmetic science and dermatology literature as a topical neuropeptide for wrinkle appearance reduction, but no regulatory medicinal status is claimed for this product.
- Marketed and positioned as a cosmetic/technical peptide ingredient (Argireline) for use in anti Ageing skincare formulations; it is not presented as a licensed medicinal product or medical device.
- No specific GMP certificates, ISO certifications, cosmetic notification references (e.g. CPNP) or other regulatory approvals for this particular 200 mg product are publicly listed by the seller.
- Argireline (Acetyl Hexapeptide 8/3) is widely used as a cosmetic ingredient globally and is discussed in cosmetic science and dermatology literature as a topical neuropeptide for wrinkle appearance reduction, but no regulatory medicinal status is claimed for this product.
Topical neuropeptide (Argireline) for anti-wrinkle skincare formulations
Description
Acetyl Hexapeptide-3 (Argireline) 200mg is described by the seller as a scientifically advanced peptide designed to reduce fine lines and wrinkles by relaxing facial muscles, making it a highly effective non-invasive alternative to Botox. It is promoted as a premium-quality Argireline ingredient suitable for skincare professionals, retailers and individuals looking to enhance anti-ageing formulations. According to the product text, it is ideal for use in high-performance serums, creams and professional treatments aimed at visible skin rejuvenation, helping to reduce wrinkle depth, prevent the formation of new lines, support skin elasticity and improve moisture retention.
Bnefits
- Scientifically advanced peptide designed to reduce fine lines and wrinkles by relaxing facial muscles, described by the seller as a non-invasive alternative to Botox.
- Clinically associated (in the product description) with helping to reduce wrinkle depth and preventing new lines from forming.
- Positioned as a versatile cosmetic active suitable for use in anti-ageing serums, moisturisers and professional skincare treatments.
- Promoted as a high-purity peptide ingredient suitable for dermatologists, aestheticians and skincare brands formulating anti-ageing products.
- Marketed benefits include improving skin elasticity, enhancing moisture retention and contributing to a smoother, more youthful appearance of the skin.
- Offered in bulk quantity (200 mg) making it suitable for professionals and retailers who wish to incorporate Argireline into multiple skincare formulations.
Indications
- Cosmetic use as an active ingredient in topical anti-ageing skincare formulations such as serums, creams and professional treatments aimed at reducing the appearance of fine lines and wrinkles.
- Use by skincare professionals, aestheticians, dermatology clinics and skincare brands to enhance anti-ageing product ranges with a peptide marketed as a non-invasive alternative to Botox.
- Use by consumers (indirectly, via finished products) seeking visibly firmer, smoother and younger-looking skin through topical applications containing Acetyl Hexapeptide-3 (Argireline).
Composition
- Active ingredient: Acetyl Hexapeptide-3 / Acetyl Hexapeptide-8 (Argireline), a synthetic hexapeptide with the amino acid sequence Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2 and CAS number 616204-22-9, widely described in the scientific and cosmetic ingredient literature as Argireline.
- Chemical formula for acetyl hexapeptide-8/3 (Argireline): C34H60N14O12S, as reported in chemical and cosmetic ingredient databases.
- INCI name commonly used for this peptide in cosmetics: Acetyl Hexapeptide-8 (historically also referred to as Acetyl Hexapeptide-3) and marketed under the trade name Argireline.
- The seller’s listing identifies the quantity as 200 mg of Acetyl Hexapeptide-3 (Argireline); no additional excipients, stabilisers, solvents or formulation details are publicly specified for this particular product.
- Purity level, salt form (e.g. acetate) and exact physical form (e.g. lyophilised powder vs solution) for this specific 200 mg product are not publicly listed by the seller.
Formulation
- Cosmetic/technical ingredient supplied as 200 mg of Acetyl Hexapeptide-3 (Argireline) intended for incorporation into topical skincare formulations; the seller positions it as suitable for serums, creams and professional treatments.
- Described as a neurotransmitter-inhibitory cosmetic peptide that acts by relaxing facial muscles, used in anti-ageing products that target expression lines and wrinkles.
- Offered primarily to skincare professionals, dermatology practices, aestheticians and skincare brands as a bulk active ingredient rather than as a finished consumer-ready cosmetic product.
- Specific dosage form (e.g. lyophilised powder, solution) and any accompanying solvents or stabilising agents for this particular 200 mg pack are not publicly detailed on the accessible product description.
Packaging
- Supplied as a 200 mg quantity of Acetyl Hexapeptide-3 (Argireline); exact primary container type (e.g. glass vial) is not explicitly described in the publicly accessible product text.
- Retail presentation appears to be a single-unit pack of 200 mg peptide for professionals and advanced users; no information is provided on secondary packaging, labelling artwork or materials.
- No additional information is publicly listed regarding tamper-evident features, batch/lot labelling or expiry dating on the packaging.
Usage
- Not publicly listed – the product is marketed as a bulk cosmetic active ingredient for use by skincare professionals, formulators and brands, who are expected to incorporate it into serums, creams or professional treatments according to their own formulation protocols and regulatory requirements.
- Consumers are not provided with direct end-user application instructions for this raw ingredient; directions for use would normally be provided with the finished cosmetic formulation containing the peptide.
Contraindications
- Not publicly listed
- As a cosmetic/technical ingredient, any contraindications, precautions and suitability for particular skin types or conditions would normally be defined by the finished product manufacturer and should follow applicable cosmetic regulations; no specific contraindications are specified in the seller’s public product description.
Adverse Effects
- Not publicly listed
- Available cosmetic and dermatological literature on Argireline primarily discusses its proposed mechanism and wrinkle-reducing effects; publicly accessible safety summaries for this specific 200 mg product from this seller are not provided.
Storage Conditions
- Not publicly listed
- No explicit guidance is provided on the seller’s public product page regarding recommended storage temperature, protection from light or humidity, or shelf-life for this 200 mg peptide ingredient; users are expected to follow any instructions printed on the product label or accompanying documentation.
Duration
Not a medical product
Onset
Not a medical product
